The SumaNurica story began in 2001 in the medical grade laboratories at biotechnology company H-KBiotech. Here, a team of scientists focused exclusively on pioneering research in proteins and peptides, utilising the latest biotechnological techniques. To date, they have developed over 115 patents and lead the way in bio-regeneration for both the medical and skincare industries.
One of their vital breakthroughs - a synthesised collagen near identical to human collagen – a 100% hydrophilic formulation, integrating type I and type III collagen in a precise ratio of 0.96:1, mirroring the natural collagen composition of our skin when we were babies.
The combination of both collagen type I and type III, which are essential components of our own skin and naturally decline over time, work to target and provide much-needed structural support and elasticity by replenishing what is lost with age.
Another breakthrough is the establishment of the H-K International Peptide Bank, containing 175,000 peptides with superior absorption, quality and stability. Discoveries such as these have paved the way for the exploration of biotech skincare and form the foundation for SumaNurica’s vision.
Constantly innovating, the SumaNurica R&D team strive to create biomimetic ingredients of the highest purity and quality, targeting common skin concerns such as skin health and ageing.
By using these advanced biotechnological methods, we can harness the power of nature to create results driven skincare that is both more effective and sustainable. The result is safe and effective products powered by proteins and peptides, that are expanding the potential of skincare. This is why the future of skincare is biotechnology.
Harness your skin’s potential with safe, effective, biomimetic skincare that works at a cellular level to stimulate the production of key structural proteins like collagen and elastin and improve overall skin health.
